DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...
The study will compare the safety and efficacy of excimer laser atherectomy utilizing the Spectranetics’ Turbo-Tandem and Turbo Elite products in conjunction with balloon angioplasty, with that of ...
COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...
February 5, 2010 (Washington, DC) — Transvenous extraction of implanted-device leads using a laser catheter is nearly always completed successfully and poses little risk of death or other major ...
Colorado Springs, CO The Spectranetics Corporation announced today that it has received FDA approval to market its Point 9 catheters with more laser energy than previously used. The Point 9 catheter ...
Renee Dicks works on stranding laser catheters which may be used to vaporize arterial blockages or assist with removing the flexible cord that connects a pacemaker to the heart, known as a lead, at ...
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in ...
According to a recent press release, Colorado Springs-based Spectranetics announced that it has received FDA 510(k) clearance for its Turbo-Power™ Laser Atherectomy Catheter, a peripheral atherectomy ...
Getting your Trinity Audio player ready... COLORADO SPRINGS — Spectranetics Corp. said Tuesday it will pay $5 million to end a government investigation into allegations it imported and marketed ...
Shares of Spectranetics ($SPNC), the maker of medical lasers, hit a 6-month low in heavy trading after it reported lower quarterly earnings and trimmed its forecast ...
Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...